All articles
The Complete Guide to Mounjaro® Dosing for Effective Weight Loss
Reading time:
5 min
Weight loss
Get expert guidance and a personalized care plan designed around you.
Recommended Weekly Dose Schedule for Mounjaro®
To assist in the practical application of Mounjaro®, here is a table outlining the recommended weekly dose schedule. Remember, your healthcare provider will work with you to provide personalized guidance and ensure you’re on the right plan for your individualized goals and unique experience.
Regular follow-ups with your healthcare provider are crucial to assess how well you respond to the treatment and make any necessary adjustments. Always adhere to prescribed instructions to ensure the safe and effective use of Mounjaro®.
Why Proper Mounjaro® Dosing is Essential
Adhering to proper dosing protocols for Mounjaro® is important for several reasons:
Maximizing Efficacy: Consistent dosing ensures that you are harnessing the full potential of Mounjaro® for optimal weight loss outcomes. (5) If a dose is missed, administer it as soon as possible within a 4-day window, then resume your regular schedule. If more than 4 days have passed, simply skip the missed dose and resume with the next scheduled weekly dose. (5)
Minimizing Side Effects: Following dosing guidelines helps mitigate the risk of potential side effects and ensures a safe and effective weight loss journey. (2,5)
Promoting Long-Term Success: Establishing a routine for Mounjaro® dosing sets the foundation for long-term weight management success and overall health improvement. (2,5)
Key Takeaways For Managing Your Mounjaro® Treatment
Proper dosing of Mounjaro® is not just about following a regimen; it's a commitment to your health and well-being. Understanding how Mounjaro® works, embracing its benefits, and adhering to dosing recommendations pave the way for a transformative weight loss journey. Remember, consistency is key, and with Mounjaro® as your ally, achieving your weight loss goals becomes a reality.
Results and dosing depend on several factors, including health history, starting BMI, tolerance to medication, and more. At Mochi Health, we tailor our services to each unique weight management path with specialized support and research-backed care. Learn about our medication options, including GLP-1s, and find out if you’re eligible for Mochi Health’s treatment program. Get started today to receive comprehensive support and guidance throughout your transformative journey.
References:
Anderson, S. L., & Marrs, J. C. (2023). Tirzepatide for type 2 diabetes. Drugs in context, 12, 2023-6-1. https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37664792/
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. https://www.nejm.org/doi/full/10.1056/NEJMoa2206038
Willard, F. S., Douros, J. D., Gabe, M. B., Showalter, A. D., Wainscott, D. B., Suter, T. M., Capozzi, M. E., van der Velden, W. J., Stutsman, C., Cardona, G. R., Urva, S., Emmerson, P. J., Holst, J. J., D'Alessio, D. A., Coghlan, M. P., Rosenkilde, M. M., Campbell, J. E., & Sloop, K. W. (2020). Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI insight, 5(17), e140532. https://doi.org/10.1172/jci.insight.140532
Urva, S., Coskun, T., Loghin, C., Cui, X., Beebe, E., O'Farrell, L., Briere, D. A., Benson, C., Nauck, M. A., & Haupt, A. (2020). The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists. Diabetes, obesity & metabolism, 22(10), 1886–1891. https://doi.org/10.1111/dom.14110
Food and Drug Administrator. (n.d.-b). Mounjaro®TM (tirzepatide) injection, for subcutaneous use. Access Data FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
Farhana A, Rehman A. Metabolic Consequences of Weight Reduction. Updated 2023 Jul 1. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan. https://www.ncbi.nlm.nih.gov/books/NBK572145/
This post was written by our team of health writers for informational purposes only and does not constitute medical advice. Always consult your doctor or healthcare provider for personalized guidance regarding your health. Ozempic®, Wegovy®, Mounjaro®®, and Zepbound® and their delivery device are registered trademarks. Mochi Health is a telehealth clinic that offers prescriptions for these products by medical necessity only as determined by a licensed health provider.
Share this post
Weight loss
More articles
Read next
For iOS & Android
